Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2009-4-2
pubmed:abstractText
The design and synthesis of a novel series of oxazole-, thiazole-, and imidazole-based inhibitors of IkappaB kinase (IKK) are reported. Biological activity was improved compared to the pyrazolopurine lead, and the expedient synthesis of the new tricyclic systems allowed for efficient exploration of structure-activity relationships. This, combined with an iterative rat cassette dosing strategy, was used to identify compounds with improved pharmacokinetic (PK) profiles to advance for in vivo evaluation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1520-4804
pubmed:author
pubmed-author:BarrishJoel CJC, pubmed-author:BelangerDominiqueD, pubmed-author:BurkeJames RJR, pubmed-author:ChenLaishunL, pubmed-author:DasJagabandhuJ, pubmed-author:DoddJohn HJH, pubmed-author:DodierMarcoM, pubmed-author:DyckmanAlaric JAJ, pubmed-author:FurchJoseph AJA, pubmed-author:GillPatriceP, pubmed-author:GilloolyKathleenK, pubmed-author:GuoJunqingJ, pubmed-author:KempsonJamesJ, pubmed-author:LangevineCharles MCM, pubmed-author:LiTianleT, pubmed-author:MarathePunit HPH, pubmed-author:MarinierAnneA, pubmed-author:MartelAlainA, pubmed-author:McIntyreKim WKW, pubmed-author:McKinnonMurrayM, pubmed-author:MoquinRobert VRV, pubmed-author:NirschlDavidD, pubmed-author:PattoliMark AMA, pubmed-author:PittsWilliam JWJ, pubmed-author:QuesnelleClaudeC, pubmed-author:SpergelSteven HSH, pubmed-author:Van KirkKatyK, pubmed-author:Wang-IversonDavidD, pubmed-author:WattersonScott HSH, pubmed-author:YangZhengZ
pubmed:issnType
Electronic
pubmed:day
9
pubmed:volume
52
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1994-2005
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:19267461-Animals, pubmed-meshheading:19267461-Crystallography, X-Ray, pubmed-meshheading:19267461-Female, pubmed-meshheading:19267461-Glutathione Transferase, pubmed-meshheading:19267461-Heterocyclic Compounds, 3-Ring, pubmed-meshheading:19267461-Humans, pubmed-meshheading:19267461-I-kappa B Kinase, pubmed-meshheading:19267461-Imidazoles, pubmed-meshheading:19267461-Leukocytes, Mononuclear, pubmed-meshheading:19267461-Lipopolysaccharides, pubmed-meshheading:19267461-Mice, pubmed-meshheading:19267461-Mice, Inbred BALB C, pubmed-meshheading:19267461-Microsomes, Liver, pubmed-meshheading:19267461-Oxazoles, pubmed-meshheading:19267461-Rats, pubmed-meshheading:19267461-Recombinant Fusion Proteins, pubmed-meshheading:19267461-Structure-Activity Relationship, pubmed-meshheading:19267461-Thiazoles, pubmed-meshheading:19267461-Tumor Necrosis Factor-alpha
pubmed:year
2009
pubmed:articleTitle
Novel tricyclic inhibitors of IkappaB kinase.
pubmed:affiliation
Departments of Discovery Chemistry, Discovery Biology, and Metabolism and Pharmacokinetics and Synthesis and Analysis Technology Team, Bristol-Myers Squibb Research and Development, Princeton, New Jersey 08543-4000, USA.
pubmed:publicationType
Journal Article, In Vitro